[Retracted] IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">ID</td><td class="align_center">Name</td><td class="align_center">Drug type</td><td class="align_center">Targets</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">DB00004</td><td class="align_center">Denileukin diftitox</td><td class="align_center">Biotech</td><td class="align_center">IL2RA, IL2RB, IL2RG</td></tr><tr><td class="align_left">DB00041</td><td class="align_center">Aldesleukin</td><td class="align_center">Biotech</td><td class="align_center">IL2RA, IL2RB, IL2RG</td></tr><tr><td class="align_left">DB00111</td><td class="align_center">Daclizumab</td><td class="align_center">Biotech</td><td class="align_center">C1QA, C1QB, C1QC, C1R, FCGR1A, FCGR2A, FCGR2B, FCGR2C, FCGR3A, FCG..</td></tr><tr><td class="align_left">DB00074</td><td class="align_center">Basiliximab</td><td class="align_center">Biotech</td><td class="align_center">C1QA, C1QB, C1QC, C1R, C1S, FCGR1A, FCGR2A, FCGR2B, FCGR2C, FCGR3A</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The relationship between IL2RB gene and target genes of anti-tumor drugs.</div>

Journal of Oncology

tab3

Table 3

Table 3: [Retracted] IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer 